Nov. 27 (UPI) -- Teva Pharmaceutical's long-awaited generic version of the EpiPen was announced Tuesday, but it offers no relief in the cost of the drug.
Teva's injector device for life-threatening allergies will be available in limited doses in the United States for $300, the same price as the generic already on the market by Mylan, the EpiPen brand-maker.